INTERNATIONAL PATENT: AVEXO PHARMACEUTICALS INC FILES APPLICATION FOR "COMPOSITIONS AND METHODS FOR MODULATING INTER-ALPHA-TRYPSIN INHIBITOR H4 ISOFORM (ITIH4) ACTIVITY"

GENEVA, March 19 -- AVEXO PHARMACEUTICALS INC (106 Sewall AveApt 6Brookline, MA 02446) filed a patent application (PCT/US2025/045040) for "COMPOSITIONS AND METHODS FOR MODULATING INTER-ALPHA-TRYPSIN INHIBITOR H4 ISOFORM (ITIH4) ACTIVITY" on Sep 05, 2025. With publication no. WO/2026/055429, the details related to the patent application was published on Mar 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KHODADOUST, Mehran M. (106 Sewall AveApt 6Brookline, MA 02446)

Abstract: The invention features compositions and methods of treatment for immune-driven conditions that target ITIH4 activ...